Shareholders in Rocket | 😈😲😔 Drugs Information, Side Effects, Reviews and Dosage | Everyday Health - Page 1 | Everyday Health

Latest FDA News

Ongoing | Cancer Accelerated Approvals

This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have postmarketing requirement(s) for ongoing clinical trial(s) to verify clinical benefit.

Verified Clinical Benefit | Cancer Accelerated Approvals

This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications with postmarketing trials that have verified clinical benefit and for which traditional approval has been subsequently granted for the specific indication.

Electronic Registration and Listing Compliance Program

Establishment registration and drug listing data is submitted by drug manufacturers and own label drug distributors through electronic means using Structured Product Labeling format (SPL).

Liver Toxicity Knowledge Base (LTKB)

Overview of the Liver Toxicity Knowledge Base project at the FDA's National Center for Toxicological Research to study drug-induced liver injury (DILI) with links to the LTKB Dataset, DILIrank and DILIst Datasets, references, and contact information for questions, suggestions, or technical support.

Patient Engagement Collaborative

The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Office of Patient Affairs in the Office of Clinical Policy and Programs (OCPP).

Medical Disclaimer

Drugs A-Z provides drug information from Everyday Health and our partners, as well as ratings from our members, all in one place. Cerner Multum™ provides the data within some of the Overview, Uses, Warnings, Side Effects, Pregnancy, Interactions, Dosage, Overdose, and Images sections. The information within all other sections is proprietary to Everyday Health.